Industry Reports

Amphastar Pharmaceuticals, Inc. (AMPH) - Financial and Strategic SWOT Analysis Review

Tuesday, Apr 12, 2016

Amphastar Pharmaceuticals, Inc. (Amphastar) is a specialty pharmaceutical company which focuses on the development, manufacturing and marketing of proprietary and generic injectable and inhalation products. It also sells insulin active pharmaceutical ingredient (insulin API) products. Amphastar’s products include enoxaparin sodium injection; cosyntropin for injection; morphine Sulfate Injection, USP; Lidocaine HCl Jelly, USP 2%; phytonadione injection; epinephrine Injection; naloxone HCl injection; Lidocaine HCl, 4% Topical Solution; and phytonadione injection. The company offers its products to hospitals, long-term care facilities, alternate care sites, clinics and doctors’ offices The company operates manufacturing facilities in Rancho Cucamonga and South El Monte, California; Canton, Massachusetts; Eragnysur-Epte, France; and Nanjing, China. It market products through specialty distributors, wholesalers, retailers and subsidiaries in the US, France and China. Amphastar is headquartered in Rancho Cucamonga, California, the US.

Read More>